134 related articles for article (PubMed ID: 18093780)
1. Area of paradoxical signal drop after the administration of superparamagnetic iron oxide on the T2-weighted image of a patient with lymphangitic metastasis of the liver.
Lee Y; Lee JS; Kim CM; Jeong JY; Choi JI; Kim MJ
Magn Reson Imaging; 2008 May; 26(4):577-82. PubMed ID: 18093780
[TBL] [Abstract][Full Text] [Related]
2. The mechanism of ring enhancement in hepatocellular carcinoma on superparamagnetic iron oxide-enhanced T1-weighted images: an investigation into peritumoral Kupffer cells.
Tanimoto A; Wakabayashi G; Shinmoto H; Okuda S; Kuribayashi S; Mukai M
J Magn Reson Imaging; 2005 Mar; 21(3):230-6. PubMed ID: 15723373
[TBL] [Abstract][Full Text] [Related]
3. Arterioportal shunts in cirrhotic patients: evaluation of the difference between tumorous and nontumorous arterioportal shunts on MR imaging with superparamagnetic iron oxide.
Mori K; Yoshioka H; Itai Y; Okamoto Y; Mori H; Takahashi N; Saida Y
AJR Am J Roentgenol; 2000 Dec; 175(6):1659-64. PubMed ID: 11090400
[TBL] [Abstract][Full Text] [Related]
4. MR imaging with i.v. superparamagnetic iron oxide: efficacy in the detection of focal hepatic lesions.
Winter TC; Freeny PC; Nghiem HV; Mack LA; Patten RM; Thomas CR; Elliott S
AJR Am J Roentgenol; 1993 Dec; 161(6):1191-8. PubMed ID: 8249724
[TBL] [Abstract][Full Text] [Related]
5. Superparamagnetic iron oxide-mediated hepatic signal intensity change in patients with and without cirrhosis: pulse sequence effects and Kupffer cell function.
Tanimoto A; Yuasa Y; Shinmoto H; Jinzaki M; Imai Y; Okuda S; Kuribayashi S
Radiology; 2002 Mar; 222(3):661-6. PubMed ID: 11867782
[TBL] [Abstract][Full Text] [Related]
6. Contrast-enhanced FDG-PET/CT vs. SPIO-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation.
Rappeport ED; Loft A; Berthelsen AK; von der Recke P; Larsen PN; Mogensen AM; Wettergren A; Rasmussen A; Hillingsoe J; Kirkegaard P; Thomsen C
Acta Radiol; 2007 May; 48(4):369-78. PubMed ID: 17453514
[TBL] [Abstract][Full Text] [Related]
7. [Use of SPIO-enhanced T1- and T2-weighted images for the differentiation of liver lesions: an ROC analysis].
Stroszczynski C; Gaffke G; Gretschel S; Rambow A; Jost D; Schlecht I; Schneider U; Schicke B; Hohenberger P; Gebauer B; Felix R
Rofo; 2003 Oct; 175(10):1368-75. PubMed ID: 14556106
[TBL] [Abstract][Full Text] [Related]
8. [Dynamic and static MRI using superparamagnetic MRI contrast medium Resovist for visualizing primary and secondary liver tumors].
Vogl TJ; Schwarz W; Hammerstingl R; Kümmel S; Balzer JO; Mack MG; Diebold T; Balzer T; Shamsi K; Bechstein WO; Schrem H; Neuhaus P; Felix R
Rofo; 1997 Sep; 167(3):264-73. PubMed ID: 9376555
[TBL] [Abstract][Full Text] [Related]
9. Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis.
Reimer P; Jähnke N; Fiebich M; Schima W; Deckers F; Marx C; Holzknecht N; Saini S
Radiology; 2000 Oct; 217(1):152-8. PubMed ID: 11012438
[TBL] [Abstract][Full Text] [Related]
10. [Differential diagnosis of focal liver lesions with MRI using the superparamagnetic contrast medium endorem].
Vogl TJ; Hammerstingl R; Keck H; Felix R
Radiologe; 1995 Nov; 35(11 Suppl 2):S258-66. PubMed ID: 8588032
[TBL] [Abstract][Full Text] [Related]
11. [Magnetic resonance imaging of hepatic focal lesions: dynamic contrastographic evaluation with gadolinium versus reticulo-endothelial hepato-specific contrast media].
Di Cesare E; Cariello G; Barile A; Sabatini M; Michelini O; Erriquez D; Masciocchi C
Radiol Med; 2000 Oct; 100(4):245-50. PubMed ID: 11155451
[TBL] [Abstract][Full Text] [Related]
12. [Differential diagnosis of intra- and perilienal tumors by use of a RES-specific MRI contrast agent].
Gaffke G; Stroszczynski C; Gnauck M; Jost D; Chmelik P; Ludwig WD; Gretschel S; Felix R
Rontgenpraxis; 2004; 55(5):192-9. PubMed ID: 15700656
[TBL] [Abstract][Full Text] [Related]
13. Quantification of superparamagnetic iron oxide (SPIO)-labeled cells using MRI.
Rad AM; Arbab AS; Iskander AS; Jiang Q; Soltanian-Zadeh H
J Magn Reson Imaging; 2007 Aug; 26(2):366-74. PubMed ID: 17623892
[TBL] [Abstract][Full Text] [Related]
14. Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading.
Imai Y; Murakami T; Yoshida S; Nishikawa M; Ohsawa M; Tokunaga K; Murata M; Shibata K; Zushi S; Kurokawa M; Yonezawa T; Kawata S; Takamura M; Nagano H; Sakon M; Monden M; Wakasa K; Nakamura H
Hepatology; 2000 Aug; 32(2):205-12. PubMed ID: 10915725
[TBL] [Abstract][Full Text] [Related]
15. Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis.
Ward J; Naik KS; Guthrie JA; Wilson D; Robinson PJ
Radiology; 1999 Feb; 210(2):459-66. PubMed ID: 10207430
[TBL] [Abstract][Full Text] [Related]
16. Using superparamagnetic iron oxide-enhanced MRI to differentiate metastatic hepatic tumors and nonsolid benign lesions.
Kumano S; Murakami T; Kim T; Hori M; Okada A; Sugiura T; Noguchi Y; Kawata S; Tomoda K; Nakamura H
AJR Am J Roentgenol; 2003 Nov; 181(5):1335-9. PubMed ID: 14573430
[TBL] [Abstract][Full Text] [Related]
17. Early radiation effects on the liver demonstrated on superparamegnetic iron oxide-enhanced T1-weighted MRI.
Mori H; Yoshioka H; Ahmadi T; Saida Y; Ohara K; Itai Y
J Comput Assist Tomogr; 2000; 24(4):648-51. PubMed ID: 10966203
[TBL] [Abstract][Full Text] [Related]
18. Alterations in hepatic uptake and distribution of organ-specific superparamagnetic MRI contrast media: clinical findings and classification according to pathogenesis.
Macarini L; Marini S; Murrone M; Ettorre GC
Radiol Med; 2004; 108(1-2):92-106. PubMed ID: 15269693
[TBL] [Abstract][Full Text] [Related]
19. Quantitative assessment of iron-oxide-enhanced magnetic resonance imaging of the liver: Vessel isointensity is a potential characteristic of liver hemangiomas on late T1-weighted images.
Schmitz SA; Nikolova A; O'Regan D; Albrecht T; Hohmann J; Wolf KJ
Acta Radiol; 2006 Sep; 47(7):634-42. PubMed ID: 16950695
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging.
Lutz AM; Willmann JK; Goepfert K; Marincek B; Weishaupt D
Radiology; 2005 Nov; 237(2):520-8. PubMed ID: 16192317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
